Cisplatin versus carboplatin in combination with third-generation drugs for advanced non-small cell lung cancer-Reference-Cited by-同舟云学术

Cisplatin versus carboplatin in combination with third-generation drugs for advanced non-small cell lung cancer

Published:2013-08-16 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

de Castria Tiago B¹,da Silva Edina MK²,Gois Aecio FT³,Riera Rachel⁴

Affiliation:

1. Instituto do Câncer do Estado de Sao Paulo (ICESP/FMUSP); Clinical Oncology; Av. Doutor Arnaldo 251 - Cerquiera César São Paulo Brazil 01246-000

2. Universidade Federal de São Paulo; Emergency Medicine and Evidence Based Medicine; Rua Borges Lagoa 564 cj 64 Vl. Clementino São Paulo São Paulo Brazil 04038-000

3. Escola Paulista de Medicina, Universidade Federal de São Paulo; Brazilian Cochrane Centre; Rua Pedro de Toledo, 598 São Paulo São Paulo Brazil 04039-001

4. Centro de Estudos de Medicina Baseada em Evidências e Avaliação Tecnológica em Saúde; Brazilian Cochrane Centre; R. Borges Lagoa, 564 cj 63 São Paulo São Paulo Brazil 04038000

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD009256.pub2/fullpdf

Reference44 articles.

1. Comparison of efficacy and toxicity between gemcitabine plus carboplatin and gemcitabine plus cisplatin in the treatment of advanced non-small cell lung cancer;Cai;Zhongguo Fei Ai Za Zhi,2002

2. A phase II randomized study of paclitaxel plus carboplatin or cisplatin against chemo-naive inoperable non-small cell lung cancer in the elderly;Chen;Journal of Thoracic Oncology,2006

3. British Thoracic Oncology Group Trial, BTOG2: Randomised phase III clinical trial of gemcitabine (1250mg/m2) combined with cisplatin 50 mg/m2 (GC50) versus cisplatin 80 mg/m2 (GC80) versus carboplatin AUC 6 (GCb6) in advanced NSCLC;Ferry;Thorax,2011

4. Randomized, multinational, phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer: the TAX 326 study group;Fossella;Journal of Clinical Oncology,2003

5. Randomized, multicenter, phase II study of gemcitabine plus cisplatin versus gemcitabine plus carboplatin in patients with advanced non-small cell lung cancer;Mazzanti;Lung Cancer,2003

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prävention, Diagnostik, Therapie und Nachsorge des Lungenkarzinoms;Pneumologie;2023-10

2. Cisplatin Dependent Secretion of Immunomodulatory High Mobility Group Box 1 (HMGB1) Protein from Lung Cancer Cells;Biomolecules;2023-08-31

3. Non-oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up;Annals of Oncology;2023-04

4. Peptides Targeting RNA m ⁶ A Methylations Influence the Viability of Cancer Cells;ChemMedChem;2023-01-23

5. The regulatory role of autophagy-related miRNAs in lung cancer drug resistance;Biomedicine & Pharmacotherapy;2022-04